TG01
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TG01, covering 2010-03-17 to 2020-05-14. Get the full timeline:
Most recent: Clinical Trial Update: Antigen-specific Cancer Immunotherapy (TG01) and Gemcitabine as Adjuvant Therapy in Resected Pancreatic Cancer [Phase 1, Phase 2]